NDC Package 61269-660-20 Zyprexa Relprevv

Olanzapine Pamoate Kit Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61269-660-20
Package Description:
1 KIT in 1 CARTON * 1.4 mL in 1 VIAL (61269-663-01) * 3 mL in 1 VIAL (61269-670-01)
Product Code:
Proprietary Name:
Zyprexa Relprevv
Non-Proprietary Name:
Olanzapine Pamoate
Usage Information:
Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It may also be used in combination with other medication to treat depression. This medication can help to decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Olanzapine belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section.
11-Digit NDC Billing Format:
61269066020
NDC to RxNorm Crosswalk:
  • RxCUI: 1718925 - OLANZapine 405 MG Extended Release Injection
  • RxCUI: 1718925 - olanzapine 405 MG Injection
  • RxCUI: 1718925 - olanzapine 405 MG (as olanzapine pamoate monohydrate 931 MG) Injection
  • RxCUI: 1718928 - ZyPREXA Relprevv 405 MG Injection
  • RxCUI: 1718928 - olanzapine 405 MG Injection [Zyprexa]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    H2-pharma Llc
    Dosage Form:
    Kit - A packaged collection of related material.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Sample Package:
    No
    FDA Application Number:
    NDA022173
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    12-11-2009
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61269-660-20?

    The NDC Packaged Code 61269-660-20 is assigned to a package of 1 kit in 1 carton * 1.4 ml in 1 vial (61269-663-01) * 3 ml in 1 vial (61269-670-01) of Zyprexa Relprevv, a human prescription drug labeled by H2-pharma Llc. The product's dosage form is kit and is administered via intramuscular form.

    Is NDC 61269-660 included in the NDC Directory?

    Yes, Zyprexa Relprevv with product code 61269-660 is active and included in the NDC Directory. The product was first marketed by H2-pharma Llc on December 11, 2009 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 61269-660-20?

    The 11-digit format is 61269066020. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-261269-660-205-4-261269-0660-20